The proposed changes to the labelling requirements of Calanus finmarchicus oil are in line with the conclusions of the safety assessment conducted by the Authority on astaxanthin. In addition, the Commission considers appropriate to lay down additional labelling requirement in order to prevent concomitant consumption of astaxanthin food supplements, which is likely to exceed the ADI established by the Authority. Therefore, it is appropriate to include additional labelling requirements for that novel food.
Recital 10, Regulation (EU) 2022/966
In forcesince 21 Jun 2022